Showing results (41-50 of 131) with videos related to

Sort By:
Pageof 14
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 15, 2022
Does receptor balance matter? - Comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP-336 on metabolic parameters in preclinical modelsA T Larsen, K E Mohamed, N Sonne, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|April 22, 2011
Post-translational modifications of the extracellular matrix are key events in cancer progression: opportunities for biochemical marker developmentD J Leeming, A C Bay-Jensen, E Vassiliadis, et al.
Osteoarthritis and Cartilage|February 28, 2006
The utility of measuring C-terminal telopeptides of collagen type II (CTX-II) in serum and synovial fluid samples for estimation of articular cartilage status in experimental models of destructive joint diseasesS Oestergaard, L Chouinard, N Doyle, et al.
Osteoarthritis and Cartilage|November 26, 2009
MAPKs are essential upstream signaling pathways in proteolytic cartilage degradation--divergence in pathways leading to aggrecanase and MMP-mediated articular cartilage degradationB-C Sondergaard, N Schultz, S H Madsen, et al.
Osteoarthritis and Cartilage|September 15, 2009
The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized studyM A Karsdal, I Byrjalsen, K Henriksen, et al.
Diabetes, Obesity & Metabolism|April 11, 2025
The Goldilocks for chronic weight management-Balancing quantity with quality of weight lossKim Henriksen, M V Chakravarthy, C L Bager, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 31, 2009
Is bone quality associated with collagen age?D J Leeming, K Henriksen, I Byrjalsen, et al.
Osteoarthritis and Cartilage|June 9, 2019
A dual amylin and calcitonin receptor agonist inhibits pain behavior and reduces cartilage pathology in an osteoarthritis rat modelA Katri, A Dąbrowska, H Löfvall, et al.
Alimentary Pharmacology & Therapeutics|May 9, 2017
Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's diseaseW T van Haaften, J H Mortensen, M A Karsdal, et al.
Biomarker Insights|November 16, 2011
Levels of Circulating MMCN-151, a Degradation Product of Mimecan, Reflect Pathological Extracellular Matrix Remodeling in Apolipoprotein E Knockout MiceN Barascuk, E Vassiliadis, Q Zheng, et al.
Pageof 14